Norden Gregory

Norden Gregory is listed in filings as Director at Royalty Pharma plc. This profile follows SEC Form 4 activity through May 15, 2026, including sale activity. Recent filings connect the profile to Royalty Pharma plc (RPRX), Zoetis Inc (ZTS), and Praxis Precision Medicines, Inc. (PRAX). The current snapshot covers public activity from Feb 18, 2025 to May 15, 2026. Reported amounts are shown as $161.4K to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.